• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于多模式疼痛治疗成功实施的核心患者报告结局指标集的验证:对描述长期成功是否有用?

Validation of a core patient-reported-outcome measure set for operationalizing success in multimodal pain therapy: useful for depicting long-term success?

作者信息

Donath Carolin, Geiß Christa, Schön Christoph

机构信息

Center for Health Services Research in Medicine, Department of Psychiatry and Psychotherapy, Friedrich-Alexander-Universität Erlangen-Nürnberg, Schwabachanlage 6, 91054, Erlangen, Germany.

Interdisciplinary Pain Center, University Clinic Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Krankenhausstr. 12, 91054, Erlangen, Germany.

出版信息

BMC Health Serv Res. 2018 Feb 17;18(1):117. doi: 10.1186/s12913-018-2911-6.

DOI:10.1186/s12913-018-2911-6
PMID:29454344
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5816476/
Abstract

BACKGROUND

The study aims to validate a previously developed and published combined success criterion for patients after multimodal pain therapy (Donath et al., BMC Health Serv Res 15:272, 2015). The criterion classifies treated patients as successful in the long term on the basis of pain severity, disability through pain, depressiveness, and health-related quality of life.

METHODS

Routine longitudinal data of 135 pain patients treated with multimodal pain therapy in 2014-2015 at the Interdisciplinary Pain Center of the University Clinic Erlangen were available at baseline, therapy start, therapy end, and 12 months after treatment. Patients were, on average, 51.0 (SD 11.1) years old and to 63.7% female, two thirds were employed (66.7%). We conducted an analysis of concurrent validity (with: pain severity, disability through pain, depressiveness, mental and physical quality of life), criterion validity (with disability days, self-rated success), convergent validity (with stress, anxiety, well-being), and discriminant validity (with chronicity of pain, comorbidity), objectivity, and reliability. Statistically, descriptive and inference statistics, graphical methods and MANOVAs were used.

RESULTS

Patients classified as successful had significantly better values on the 5 variables demonstrating concurrent validity (all p < .001), significantly fewer Disability days (M = 15.31 (SD = 23.15) vs. M = 26.75 (SD = 29.15)); t (133) = 2.308; p = .024, less Anxiety (Pillai-Spur: F (3, 131) = 2.972, p = .034), less Stress (Pillai-Spur: F (3, 131) = 9.907, p < .001), and better Well-being (Pillai-Spur: F (3, 131) = 9.594, p < .001) 12 months after treatment than patients classified as not successful. The Spearman correlation between success classification and Chronicity stage was .094 (p = .280).

CONCLUSION

We demonstrated the validity of the combined success criterion with long-term data in addition to confirming the reliability and objectivity of the criterion. Future research might consider identifying predictors of success in multi-modal pain therapy.

摘要

背景

本研究旨在验证先前制定并发表的多模式疼痛治疗后患者综合成功标准(多纳特等人,《BMC卫生服务研究》15:272,2015年)。该标准根据疼痛严重程度、因疼痛导致的残疾、抑郁程度以及与健康相关的生活质量,将接受治疗的患者长期分类为成功。

方法

2014 - 2015年在埃尔朗根大学诊所跨学科疼痛中心接受多模式疼痛治疗的135名疼痛患者的常规纵向数据在基线、治疗开始、治疗结束以及治疗后12个月时可用。患者平均年龄为51.0(标准差11.1)岁,63.7%为女性,三分之二受雇(66.7%)。我们进行了同时效度分析(与:疼痛严重程度、因疼痛导致的残疾、抑郁程度、心理和生理生活质量)、标准效度分析(与残疾天数、自我评定的成功度)、收敛效度分析(与压力、焦虑、幸福感)以及区分效度分析(与疼痛慢性程度、合并症)、客观性和可靠性分析。在统计学上,使用了描述性和推断性统计、图形方法以及多变量方差分析。

结果

被分类为成功的患者在证明同时效度的5个变量上具有显著更好的值(所有p <.001),残疾天数显著更少(M = 15.31(标准差 = 23.15)对M = 26.75(标准差 = 29.15));t(133) = 2.308;p =.024,焦虑程度更低(皮莱 - 斯布尔检验:F(3, 131) = 2.972,p =.034),压力更低(皮莱 - 斯布尔检验:F(3, 131) = 9.907,p <.001),并且在治疗后12个月时的幸福感更好(皮莱 - 斯布尔检验:F(3, 131) = 9.594,p <.001),比被分类为不成功的患者。成功分类与慢性程度阶段之间的斯皮尔曼相关性为.094(p =.280)。

结论

除了确认该标准的可靠性和客观性之外,我们还用长期数据证明了综合成功标准的效度。未来的研究可能会考虑确定多模式疼痛治疗成功的预测因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9cc/5816476/c0933901d121/12913_2018_2911_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9cc/5816476/c17b35d62597/12913_2018_2911_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9cc/5816476/823d8d52f02a/12913_2018_2911_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9cc/5816476/4af08fd6c541/12913_2018_2911_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9cc/5816476/71c2e57bed0a/12913_2018_2911_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9cc/5816476/2968b6e82999/12913_2018_2911_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9cc/5816476/c0933901d121/12913_2018_2911_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9cc/5816476/c17b35d62597/12913_2018_2911_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9cc/5816476/823d8d52f02a/12913_2018_2911_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9cc/5816476/4af08fd6c541/12913_2018_2911_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9cc/5816476/71c2e57bed0a/12913_2018_2911_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9cc/5816476/2968b6e82999/12913_2018_2911_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9cc/5816476/c0933901d121/12913_2018_2911_Fig6_HTML.jpg

相似文献

1
Validation of a core patient-reported-outcome measure set for operationalizing success in multimodal pain therapy: useful for depicting long-term success?用于多模式疼痛治疗成功实施的核心患者报告结局指标集的验证:对描述长期成功是否有用?
BMC Health Serv Res. 2018 Feb 17;18(1):117. doi: 10.1186/s12913-018-2911-6.
2
Searching for success: Development of a combined patient-reported-outcome ("PRO") criterion for operationalizing success in multi-modal pain therapy.探寻成功之道:制定一项综合患者报告结局(“PRO”)标准以衡量多模式疼痛治疗的成功与否
BMC Health Serv Res. 2015 Jul 17;15:272. doi: 10.1186/s12913-015-0939-4.
3
A 3-month analysis of disability, quality of life, and disease course in patients with migraine.偏头痛患者残疾、生活质量和病程的 3 个月分析。
Headache. 2013 Feb;53(2):297-309. doi: 10.1111/j.1526-4610.2012.02279.x. Epub 2012 Oct 24.
4
[Outpatient multimodal pain therapy : Results of a 1-week intensive outpatient multimodal group program for patients with chronic unspecific back pain - retrospective evaluation after 3 and 12 months].[门诊多模式疼痛治疗:针对慢性非特异性背痛患者的为期1周的强化门诊多模式小组项目结果——3个月和12个月后的回顾性评估]
Schmerz. 2017 Oct;31(5):508-515. doi: 10.1007/s00482-017-0211-4.
5
Self-reported pain severity, quality of life, disability, anxiety and depression in patients classified with 'nociceptive', 'peripheral neuropathic' and 'central sensitisation' pain. The discriminant validity of mechanisms-based classifications of low back (±leg) pain.“伤害性”、“外周神经性”和“中枢敏化”疼痛患者的自我报告疼痛严重程度、生活质量、残疾情况、焦虑和抑郁。下背部(±腿部)疼痛基于机制分类的判别效度。
Man Ther. 2012 Apr;17(2):119-25. doi: 10.1016/j.math.2011.10.002. Epub 2011 Nov 9.
6
The Oswestry Disability Index (version 2.1a): validation of a Dutch language version.奥斯威斯利功能障碍指数(2.1a版):荷兰语版本的验证
Spine (Phila Pa 1976). 2015 Jan 15;40(2):E83-90. doi: 10.1097/BRS.0000000000000683.
7
Validation of the LupusPRO version 1.8: an update to a disease-specific patient-reported outcome tool for systemic lupus erythematosus.LupusPRO 1.8版的验证:系统性红斑狼疮特定疾病患者报告结局工具的更新
Lupus. 2018 Apr;27(5):728-737. doi: 10.1177/0961203317739128. Epub 2017 Oct 31.
8
Measuring participation in patients with chronic back pain-the 5-Item Pain Disability Index.测量慢性腰痛患者的参与度——5 项疼痛残疾指数。
Spine J. 2018 Feb;18(2):307-313. doi: 10.1016/j.spinee.2017.07.172. Epub 2017 Jul 20.
9
Six-and 12-month follow-up of an interdisciplinary fibromyalgia treatment programme: results of a randomised trial.一项跨学科纤维肌痛治疗方案的 6 个月和 12 个月随访:一项随机试验的结果。
Clin Exp Rheumatol. 2012 Nov-Dec;30(6 Suppl 74):103-11. Epub 2012 Dec 14.
10
The Spanish version of the Patient-Rated Wrist Evaluation outcome measure: cross-cultural adaptation process, reliability, measurement error and construct validity.患者自评腕关节评估结果测量工具的西班牙语版本:跨文化调适过程、信度、测量误差与结构效度
Health Qual Life Outcomes. 2017 Aug 24;15(1):169. doi: 10.1186/s12955-017-0745-2.

引用本文的文献

1
Cross-cultural adaptation and validation of the German Central Sensitization Inventory (CSI-GE).跨文化调适与验证德国中枢敏化量表(CSI-GE)。
BMC Musculoskelet Disord. 2021 Aug 18;22(1):708. doi: 10.1186/s12891-021-04481-5.

本文引用的文献

1
[Patient perspectives in outcome research : Development of a focus group concept for collating patient perspectives on determination of effectiveness of multimodal pain therapy - A pilot study].[结果研究中的患者观点:关于整理患者对多模式疼痛治疗效果判定观点的焦点小组概念的开发——一项试点研究]
Schmerz. 2017 Apr;31(2):139-148. doi: 10.1007/s00482-016-0171-0.
2
Comment on Deckert et al.: A systematic review of the outcomes reported in multimodal pain therapy for chronic pain.对德克特等人的评论:慢性疼痛多模式疼痛治疗报告结果的系统评价。
Eur J Pain. 2016 Oct;20(9):1542-4. doi: 10.1002/ejp.930.
3
Validation of the Erlangen Test of Activities of Daily Living in Persons with Mild Dementia or Mild Cognitive Impairment (ETAM).
埃尔朗根日常生活活动能力测试在轻度痴呆或轻度认知障碍患者中的效度验证(ETAM)。
BMC Geriatr. 2016 May 26;16:111. doi: 10.1186/s12877-016-0271-9.
4
Validation and application of a core set of patient-relevant outcome domains to assess the effectiveness of multimodal pain therapy (VAPAIN): a study protocol.用于评估多模式疼痛治疗有效性的一组核心患者相关结局领域的验证与应用(VAPAIN):一项研究方案
BMJ Open. 2015 Nov 6;5(11):e008146. doi: 10.1136/bmjopen-2015-008146.
5
[Depression, anxiety and stress scales: DASS--A screening procedure not only for pain patients].[抑郁、焦虑和压力量表:抑郁焦虑压力量表——一种不仅适用于疼痛患者的筛查程序]
Schmerz. 2015 Dec;29(6):649-57. doi: 10.1007/s00482-015-0019-z.
6
Searching for success: Development of a combined patient-reported-outcome ("PRO") criterion for operationalizing success in multi-modal pain therapy.探寻成功之道:制定一项综合患者报告结局(“PRO”)标准以衡量多模式疼痛治疗的成功与否
BMC Health Serv Res. 2015 Jul 17;15:272. doi: 10.1186/s12913-015-0939-4.
7
A systematic review of the outcomes reported in multimodal pain therapy for chronic pain.对多模式疼痛疗法治疗慢性疼痛所报告结果的系统评价。
Eur J Pain. 2016 Jan;20(1):51-63. doi: 10.1002/ejp.721. Epub 2015 May 29.
8
[Multimodal therapy programs for chronic pain].[慢性疼痛的多模式治疗方案]
Anaesthesist. 2015 Feb;64(2):95-107. doi: 10.1007/s00101-014-2418-4.
9
Core Outcome Measures in Effectiveness Trials (COMET) initiative: protocol for an international Delphi study to achieve consensus on how to select outcome measurement instruments for outcomes included in a 'core outcome set'.有效性试验核心结局指标(COMET)计划:一项国际德尔菲研究的方案,旨在就如何为“核心结局集”中包含的结局选择结局测量工具达成共识。
Trials. 2014 Jun 25;15:247. doi: 10.1186/1745-6215-15-247.
10
Activities of daily living in dementia: revalidation of the E-ADL Test and suggestions for further development.日常生活活动在痴呆症中的应用:E-ADL 测试的再验证及进一步发展的建议。
BMC Psychiatry. 2012 Nov 23;12:208. doi: 10.1186/1471-244X-12-208.